A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial

Introduction:Chronic kidney disease (CKD) has lots of complication like calcium and phosphate metabolism disorders, hyperparathyroidism, vitamin D deficiency and metabolic acidosis. Objectives: The aim of this study was to determine and compare the effect of calcitriol and cinacalcet on hyperparathy...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Saeed Mardani, Faranak Sadat Filsouf
Formato:	article
Lenguaje:	EN
Publicado:	Society of Diabetic Nephropathy Prevention 2022
Materias:	chronic kidney disease cinacalcet calcitriol end-stage renal disease hemodialysis Therapeutics. Pharmacology RM1-950 Diseases of the genitourinary system. Urology RC870-923
Acceso en línea:	https://doaj.org/article/a98f638592b9401a9d1e6b292585d40b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a98f638592b9401a9d1e6b292585d40b
record_format	dspace
spelling	oai:doaj.org-article:a98f638592b9401a9d1e6b292585d40b2021-11-17T08:15:00ZA comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial2345-420210.34172/npj.2022.12https://doaj.org/article/a98f638592b9401a9d1e6b292585d40b2022-01-01T00:00:00Zhttps://jnephropharmacology.com/PDF/npj-10442https://doaj.org/toc/2345-4202Introduction:Chronic kidney disease (CKD) has lots of complication like calcium and phosphate metabolism disorders, hyperparathyroidism, vitamin D deficiency and metabolic acidosis. Objectives: The aim of this study was to determine and compare the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients due to end-stage renal disease (ESRD). Patients and Methods: This study was a double-blinded randomized clinical trial, which was conducted on 60 hemodialysis patients in 2017-2018. The patients were randomly assigned to two groups of 30 patients, which one group was treated with cinacalcet and the other group was treated with calcitriol. During this study, phosphorus, calcium and iPTH were measured. Results: The results showed that in the group treated with cinacalcet, the amount of calcium [t(22)=0.294, P>0.05] and the amount of phosphorus [t(22)=1.87, P>0.05] did not change significantly while iPTH values before and after the study had statistically significant difference [t(22)=4.37, P<0.05]. In group treated with calcitriol, the calcium, phosphorus and iPTH values did not change significantly (P>0.05). Calcium changes in the cinacalcet group compared to the calcitriol group [t (47) =-1.14, P>0.05] and also, the amount of phosphorus changes [t (47) =-1.022, P>0.05] was not statistically significant. The iPTH changes were not statistically significant between the two groups however iPTH in the calcitriol group was higher than the cinacalcet group [t (47) =-1.13, P>0.05]. Conclusion: In contrast to calcitriol, cinacalcet significantly reduced iPTH and did not significantly change calcium and phosphorus levels. Trial Registration: The trial was registered by Iranian Registry of Clinical Trials (IRCT) (identifier: IRCT20190702044076N1; https://en.irct.ir/trial/40547, Ethical code# IR.SKUMS.REC.1397.026).Saeed MardaniFaranak Sadat FilsoufSociety of Diabetic Nephropathy Prevention articlechronic kidney diseasecinacalcetcalcitriolend-stage renal diseasehemodialysisTherapeutics. PharmacologyRM1-950Diseases of the genitourinary system. UrologyRC870-923ENJournal of Nephropharmacology, Vol 11, Iss 1, Pp e12-e12 (2022)
institution	DOAJ
collection	DOAJ
language	EN
topic	chronic kidney disease cinacalcet calcitriol end-stage renal disease hemodialysis Therapeutics. Pharmacology RM1-950 Diseases of the genitourinary system. Urology RC870-923
spellingShingle	chronic kidney disease cinacalcet calcitriol end-stage renal disease hemodialysis Therapeutics. Pharmacology RM1-950 Diseases of the genitourinary system. Urology RC870-923 Saeed Mardani Faranak Sadat Filsouf A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
description	Introduction:Chronic kidney disease (CKD) has lots of complication like calcium and phosphate metabolism disorders, hyperparathyroidism, vitamin D deficiency and metabolic acidosis. Objectives: The aim of this study was to determine and compare the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients due to end-stage renal disease (ESRD). Patients and Methods: This study was a double-blinded randomized clinical trial, which was conducted on 60 hemodialysis patients in 2017-2018. The patients were randomly assigned to two groups of 30 patients, which one group was treated with cinacalcet and the other group was treated with calcitriol. During this study, phosphorus, calcium and iPTH were measured. Results: The results showed that in the group treated with cinacalcet, the amount of calcium [t(22)=0.294, P>0.05] and the amount of phosphorus [t(22)=1.87, P>0.05] did not change significantly while iPTH values before and after the study had statistically significant difference [t(22)=4.37, P<0.05]. In group treated with calcitriol, the calcium, phosphorus and iPTH values did not change significantly (P>0.05). Calcium changes in the cinacalcet group compared to the calcitriol group [t (47) =-1.14, P>0.05] and also, the amount of phosphorus changes [t (47) =-1.022, P>0.05] was not statistically significant. The iPTH changes were not statistically significant between the two groups however iPTH in the calcitriol group was higher than the cinacalcet group [t (47) =-1.13, P>0.05]. Conclusion: In contrast to calcitriol, cinacalcet significantly reduced iPTH and did not significantly change calcium and phosphorus levels. Trial Registration: The trial was registered by Iranian Registry of Clinical Trials (IRCT) (identifier: IRCT20190702044076N1; https://en.irct.ir/trial/40547, Ethical code# IR.SKUMS.REC.1397.026).
format	article
author	Saeed Mardani Faranak Sadat Filsouf
author_facet	Saeed Mardani Faranak Sadat Filsouf
author_sort	Saeed Mardani
title	A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
title_short	A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
title_full	A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
title_fullStr	A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
title_full_unstemmed	A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
title_sort	comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial
publisher	Society of Diabetic Nephropathy Prevention
publishDate	2022
url	https://doaj.org/article/a98f638592b9401a9d1e6b292585d40b
work_keys_str_mv	AT saeedmardani acomparativestudyontheeffectofcalcitriolandcinacalcetonhyperparathyroidisminhemodialysispatientsadoubleblindedrandomizedclinicaltrial AT faranaksadatfilsouf acomparativestudyontheeffectofcalcitriolandcinacalcetonhyperparathyroidisminhemodialysispatientsadoubleblindedrandomizedclinicaltrial AT saeedmardani comparativestudyontheeffectofcalcitriolandcinacalcetonhyperparathyroidisminhemodialysispatientsadoubleblindedrandomizedclinicaltrial AT faranaksadatfilsouf comparativestudyontheeffectofcalcitriolandcinacalcetonhyperparathyroidisminhemodialysispatientsadoubleblindedrandomizedclinicaltrial
_version_	1718425817523945472

A comparative study on the effect of calcitriol and cinacalcet on hyperparathyroidism in hemodialysis patients; a double-blinded randomized clinical trial

Ejemplares similares